Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Last Year CEO Update

<< Previous

Bullboard Posts

Next >>

Post by Pareto8020on Nov 26, 2021 9:40am

348 Views

Post# 34168310

Last Year CEO Update

Last year SBM's fearless and clueless leader put out his CEO update - lets examine clips for amusement:

https://www.sironabiochem.com/sirona-biochem-releases-ceo-letter-to-shareholders-2/

Q: Will we have any news before the end of 2020?

Sirona’s projected milestones will occur within the next 7 months. As per our Investor PowerPoint, we have provided a list of items we feel are within our control and our goal remains to announce them within that timeframe.

Well I guess your "feeling" of what was under your control was complete pile of horse dunn.

Q: What is happening with the diabetic therapy for animals?

Our partner completed extensive due diligence that went beyond the initially set timeline. They have reported to us they are at the very final stages of that process and will be moving to the next level of engagement. We expect an update on this project soon, however, we caution that due to holidays, we cannot be certain that news will be released prior to year-end.

Maybe he meant the 2021 holidays? WTH - first they say it is so close to being done but the holidays got in the way. Then they say they have an additional partner...... then they say they have 4 partners at the table! What is next - they are now up to 8 partners and expect a deal within a decade or when the patent expires?

Q: Is Sirona going to improve investor communications?

We are actively working to improve communications. This FAQ sheet is part of that process. You will see more changes over the next few months as we work to keep our shareholders informed of our latest developments. This includes a stronger social media presence and quarterly shareholder updates.

Hilarious! Great that they brought on CURE to promote absolutely no substantial "watershed" "new era" NEWS whatsoever. Another waste of time and money by Howard. How about you firm up a deal or two (like actually close a deal by both parties signing a contract) before you bring on a company to promote your accomplishments.

For additional laughs check out their old Milestone list that was to be completed by May/June at:

https://www.sironabiochem.com/wp-content/uploads/2020/11/SBM-Investor-Presentation-November2020.pdf